Sun Pharmaceutical Industries posted a near 2 per cent year-on-year (YoY) decline in profit after tax (PAT) for the first quarter of FY24 to Rs 2,022.5 crore due to a one-time exceptional expense. The firm’s total income grew by almost 13 per cent. The firm’s stock ended flat at Rs 1,140.85 on the… Continue reading Sun Pharma Q1 PAT dips 2% on one-time expense; US revenues up 12%